Calciphylaxis is a rare disorder with high mortality, which commonly occurs, but not limited to, patients with end-stage renal disease. We present a successful case in which a patient survived this serious disorder of vasculopathy, highlighting the physical and emotional morbidities associated with this condition and alerting physicians of the key elements in its management. Further understanding of calciphylaxis may advance our knowledge in endotheliopathy and vascular ossification.
|Authors||Lee, P.; Sevastos, J.; Campbell, L. V.;|
|Responsible Garvan Author|
|Publisher Name||JOURNAL OF BONE AND MINERAL METABOLISM|
|Published Date||2009-01-01 00:00:00|
|URL link to publisher's version||http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19057838|
|OpenAccess link to author's accepted manuscript version||https://publications.gimr.garvan.org.au/open-access/10219|